Extrait

The primary objective of this trial is to demonstrate that a higher proportion of subjects with T2DM and inadequate glycemic control have a preference for an oral treatment with the SPC of vildagliptin/metformin compared to an injectable treatment with liraglutide as add-on to metformin after experiencing both treatments.

Critère d'inclusion

• Type 2 diabetes mellitus

Liens

• ictrp
• euctr